A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome)

Diseases of the Colon and Rectum

Volumn 42, Issue 1, 1999, Pages 1-9

  Thorson, Alan G ^a   Knezetic, Joseph A ^a   Lynch, Henry T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic counseling; Genetic testing; Hereditary cancer; Hereditary nonpolyposis colorectal cancer; Mismatch repair; Molecular genetics

Indexed keywords

CANCER RISK; COLORECTAL CANCER; CONFERENCE PAPER; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; HISTORY; HUMAN; MOLECULAR GENETICS; PROGNOSIS;

EID: 0032924247     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02235175     Document Type: Conference Paper

References (49)

1. Landis SH, Murray T, Bolden F, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-30.
2. Lynch HT, Smyrk TS, Lynch JF. Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch Syndrome). Historical journey from pedigree anecdote to molecular genetic confirmation. Oncology 1998;55:103-8.
3. Lynch HT, Shaw MW, Magnuson CS, Larsen AL, Krush AJ. Hereditary factors in cancer. Study of two large Midwestern kindreds. Arch Intern Med 1966;117: 206-12.
4. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-55.
5. Warthin AS. Heredity of carcinoma in man. Ann Int Med 1931;4:681-96.
6. Lynch HT, Krush AJ. Cancer family "G" revisited. 1895-1970. Cancer 1971;27:1505-11.
7. Rozen P, Lynch HT, Figer A, et al. Familial colon cancer in the Tel-Aviv area and the influence of ethnic origin. Cancer 1987;60:2355-9.
8. Mecklin J, Jarvinen HJ, Peltokallio P. Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastroenterology 1986;90:328-33.
9. Abusamra H, Maximova S, Bar-Meier S, Krispin M, Rotmensch HH. Cancer family syndrome of Lynch. Am J Med 1987;83:981-3.
10. Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmat A, Roncucci L. Familial aggregation of tumors in the three year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344-8.
11. Cristofaro G, Lynch HT, Caruso ML, et al. New phenotypic aspects in a family with Lynch syndrome II. Cancer 1987;60:51-8.
12. Boland CR, Troncale FJ. Familial colonic cancer without antecedent polyposis. Ann Intern Med 1984;100:700-1.
13. Vasen HF, Mecklin J-P, Khan PM, Lynch HT. The International Collaborative Group on HNPCC. Anticancer Res 1994;14:1661-4.
14. Vasen HF, Mecklin J-P, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
15. Lynch HT, Bardawil WA, Harris RE, et al. Multiple primary cancers and prolonged survival: familial colonic and endometrial cancers. Dis Colon Rectum 1978;21: 165-8.
16. Lynch HT, Albano W, Recabaren J, et al. Prolonged survival as a component of hereditary breast and non-polyposis colon cancer. Med Hypoth 1981;7:1201-9.
17. Albano WA, Recabaren JA, Lynch HT, et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982;50:360-3.
18. Lynch HT, Watson P, Kriegler M, et al. Differential diagnosis of hereditary non-polyposis colorectal cancer (Lynch Syndrome I & II). Dis Colon Rectum 1988;31: 372-7.
19. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary nonpolyposis colorectal cancer. Anticancer Res 1994;14:1631-4.
20. Fresco JR, Alberts BM. The accommodation of non-complementary bases in helical polyribonucleotides and the doxyribonucleic acids. Proc Natl Acad Sci USA 1960;46:311-21.
21. Streisinger G, Okada Y, Emrich J, et al. Frameshift mutations and the genetic code. Cold Spring Harb Symp Quant Biol 1966;31:77-84.
22. Wildenberg J, Meselson M. Mismatch repair and heteroduplex DNA. Proc Natl Acad Sci U S A 1975;72:2202-6.
23. Holmes J Jr, Clark F, Modrich P. Strand-specific mismatch correction in nuclear extracts of human and Drosophila melanogaster cell line. Proc Natl Acad Sci USA 1990;87:5837-41.
24. Thomas DC, Roberts JD, Kunkel TA. Heteroduplex repair in extracts of human HeLa cells. J Biol Chem 1991; 266:3744-51.
25. Ionov Y, Peinado MA, Malkhosyan F, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
26. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
27. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260: 816-9.
28. Peltomaki P, Aaltonen LA, Sistonen T, et al. Genetic mapping of a locus predisposing to human colon colorectal cancer. Science 1993;260:810-2.
29. Lindblom A, Tannergard P, Werelius B, et al. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colon cancer. Nat Genet 1993;5:279-82.
30. Fishel R, Lesco MK, Rao MR, et al The human mutator gene homologue MSH2 and its association with hereditary non-polyposis colon cancer. Cell 1993;75:1027-38.
31. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mute S homologue in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
32. Bronner CE, Baker FM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-61.
33. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutations of a mutL homologue and hereditary colon cancer. Science 1994;263:1625-9.
34. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
35. Claverys JP, Lacks SA. Heteroduplex deoxyribonucleic acid base mismatch repair in bacteria. Microbiol Rev 1986;50:133-65.
36. Modrich P. Mechanisms and biological effects of mismatch repair. Ann Rev Genet 1991;25:229-53.
37. New L, Liu K, Crouse GF. The yeast gene MSH3 defines a new class of eukaryotic MutS homologues. Mol Gen Genet 1993;239:97-108.
38. Palombo F, Gallinari P, Iaccarino I, et al. GTBP, a one hundred sixty ikilodalton proteins essential for mismatch binding activity in human cells. Science 1995; 268:19,121-914.
39. Hollingsworth NM, Ponte L, Halsey C. MSH5, a novel MutS homologue facilitates meiotic reciprocal recombination between homologues and saccharomyces cerevisiae but not mismatch repair. Genes Dev 1995;9: 1728-39.
40. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch Syndrome). An updated review. Cancer 1996;78:1149-67.
41. Lin KM, Shashidharan M, Thorson AG, et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary non-polyposis colorectal cancer. J Gastrointest Surg 1998;2:67-71.
42. Lin KM, Shashidharan M, Ternent CA, et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum, 1998;41: 428-33.
43. Vasen H, Wijnen J, Menko F, et al. Cancer risk in familles with HNPCC diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
44. Rodiguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International collaborative group on HNPCC. Ann Surg 1997;225:202-7.
45. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal cancer family members. Cancer 1998;83: 255-66.
46. Graham DM, Appelman HD. Crohn's-like lymphoid reaction in colorectal cancer: a potential histologic prognosticator. Mod Pathol 1990;3:332-5.
47. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998; 42:673-9.
48. Barth RJ Jr, Camp BJ, Martusello TA, Dain BJ, Memoli VA. The cytokine micro environment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Cancer 1996;78:1168-78.
49. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-6.